Metraipolis › archive › dc_e2689e33ccd9
Trop2-Based Antibody-Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy — Europe PMC PMID:41744856
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41744856
- DOI
- 10.3390/curroncol33020092
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:04:43.909Z
- SHA-256 of the archived text
9e347a5f2b5abbede0e87ee4bc061542d3565e95393f0bbb7f55d986417653b7- Stable URL of this page
https://metraipolis.com/documento/dc_e2689e33ccd9
How to cite
Trop2-Based Antibody-Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy — Europe PMC PMID:41744856 — Europe PMC (en), https://europepmc.org/article/MED/41744856 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2689e33ccd9 (Metraipolis archive dc_e2689e33ccd9, sha256 9e347a5f2b5abbede0e87ee4bc061542d3565e95393f0bbb7f55d986417653b7)
BibTeX
@misc{dce2689e33ccd9,
title = {Trop2-Based Antibody-Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy — Europe PMC PMID:41744856},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41744856},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2689e33ccd9; sha256 9e347a5f2b5abbede0e87ee4bc061542d3565e95393f0bbb7f55d986417653b7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41744856. Agents can read the archived copy with the MCP tool read_document.